Multipolar Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Multipolar Tbk. trades at Rp90 (market cap 1.41T, 18.17M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Multipolar Tbk. is far larger — about 8.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Multipolar Tbk. is more actively traded (18.17M versus 324K). Which is the better fit depends on your goals.
| MLPL | OBAT | |
|---|---|---|
Market Cap | 1.41T | 166.01B |
Volume | 18.17M | 324K |
Lot | 181.74K | 3.24K |
Turnover | 1.62B | 77.68M |
Average Price | 89.32 | 239.75 |
Value | 1.62B | 77.68M |
Indicative Equilibrium Price | 90 | 240 |
Indicative Equilibrium Volume | 1.66K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Multipolar Tbk (the Company) was established in the Republic of Indonesia on December 4, 1975 based on Notarial Deed No. 7 of Adlan Yulizar, S.H., which has beed amended several times, the latest by Notarial Deed No. 119 of Misahardi Wilamarta, S.H., dated March 25, 1982.
Read more on MLPL →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →